178 related articles for article (PubMed ID: 31323617)
1. Design, synthesis and antibacterial evaluation of novel 15-membered 11a-azahomoclarithromycin derivatives with the 1, 2, 3-triazole side chain.
Qin Y; Teng Y; Ma R; Bi F; Liu Z; Zhang P; Ma S
Eur J Med Chem; 2019 Oct; 180():321-339. PubMed ID: 31323617
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and structure-activity relationships of novel N11-, C12- and C13-substituted 15-membered homo-aza-clarithromycin derivatives against various resistant bacteria.
Qin Y; Song D; Teng Y; Liu X; Zhang P; Zhang N; Zhang N; Chen W; Ma S
Bioorg Chem; 2021 Aug; 113():104992. PubMed ID: 34051415
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial evaluation of novel 11-O-aralkylcarbamoyl-3-O-descladinosylclarithromycin derivatives.
Jia L; Wang Y; Wang Y; Qin Y; Hu C; Sheng J; Ma S
Bioorg Med Chem Lett; 2018 Aug; 28(14):2471-2476. PubMed ID: 29880401
[TBL] [Abstract][Full Text] [Related]
4. A novel series of 11-O-carbamoyl-3-O-descladinosyl clarithromycin derivatives bearing 1,2,3-triazole group: Design, synthesis and antibacterial evaluation.
Teng Y; Qin Y; Song D; Liu X; Ma Y; Zhang P; Ma S
Bioorg Med Chem Lett; 2020 Jan; 30(2):126850. PubMed ID: 31836439
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial evaluation of novel clarithromycin derivatives with C-4″ elongated arylalkyl groups against macrolide-resistant strains.
Ma S; Jiao B; Ju Y; Zheng M; Ma R; Liu L; Zhang L; Shen X; Ma C; Meng Y; Wang H; Qi Y; Ma X; Cui W
Eur J Med Chem; 2011 Feb; 46(2):556-66. PubMed ID: 21159410
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activity of novel 3-O-arylalkylcarbamoyl-3-O-descladinosyl-9-O-(2-chlorobenzyl)oxime clarithromycin derivatives.
Qin Y; Qiang S; Ji S; Liu Z; Hu C; Ma S
Bioorg Med Chem Lett; 2018 Nov; 28(20):3324-3328. PubMed ID: 30219527
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of antibacterial activity of novel clarithromycin derivatives incorporating 1,2,3-triazole moieties at the 4''- and 11-OH positions.
Qin Y; Sun M; Zhang N; Yang Y; Ma P
Bioorg Chem; 2022 Oct; 127():106020. PubMed ID: 35841669
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus.
Gatadi S; Gour J; Shukla M; Kaul G; Das S; Dasgupta A; Malasala S; Borra RS; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2018 Sep; 157():1056-1067. PubMed ID: 30176536
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial evaluation of novel 11-O-carbamoyl clarithromycin ketolides.
Jia L; Yan M; Shen Y; Qin Y; Qiang S; Ma S
Bioorg Med Chem Lett; 2017 Aug; 27(16):3693-3697. PubMed ID: 28711353
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationship of a novel class of 15-membered macrolide antibiotics known as '11a-azalides'.
Sugimoto T; Tanikawa T; Suzuki K; Yamasaki Y
Bioorg Med Chem; 2012 Oct; 20(19):5787-801. PubMed ID: 22925450
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibacterial activity of novel 4″-O-benzimidazolyl clarithromycin derivatives.
Cong C; Wang H; Hu Y; Liu C; Ma S; Li X; Cao J; Ma S
Eur J Med Chem; 2011 Jul; 46(7):3105-11. PubMed ID: 21524827
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antibacterial evaluation of novel C-11, C-9 or C-2'-substituted 3-O-descladinosyl-3-ketoclarithromycin derivatives.
Bai B; Bi F; Qin Y; Teng Y; Ma S
Bioorg Med Chem Lett; 2021 Jul; 43():128110. PubMed ID: 33991629
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial activities of a novel alkylide: 3-O-(3-aryl-2-propargyl) and 3-O-(3-aryl-2-propenyl)clarithromycin derivatives.
Liang JH; Wang YY; Wang H; Li XL; An K; Xu YC; Yao GW
Bioorg Med Chem Lett; 2010 May; 20(9):2880-3. PubMed ID: 20356738
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and antibacterial evaluation of novel 3-O-substituted 15-membered azalides possessing 1,2,3-triazole side chains.
Qin Y; Xu L; Teng Y; Yang Y; Wang Y; Ma P
Bioorg Med Chem Lett; 2021 Oct; 49():128330. PubMed ID: 34403726
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel macrolide derivatives with imidazo[4,5-b]pyridinyl sulfur contained alkyl side chains and their antibacterial activity.
Xu P; Liu L; Chen XZ; Li Y; Liu J; Jin ZP; Wang GQ; Lei PS
Bioorg Med Chem Lett; 2009 Aug; 19(15):4079-83. PubMed ID: 19560350
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial activity of novel 3-O-carbamoyl derivatives of clarithromycin and 11,12-cyclic carbonate azithromycin.
Zhang L; Song L; Liu Z; Li H; Lu Y; Li Z; Ma S
Eur J Med Chem; 2010 Mar; 45(3):915-22. PubMed ID: 19945195
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
Yano H; Kobayashi T; Okitsu N; Aoki A; Toriya M; Nakada Y; Sagai H; Iyobe S; Inoue M
Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Antibacterial Evaluation of Mannich Bases Derived from 1,2,4-Triazole.
Paneth A; Trotsko N; Popiołek Ł; Grzegorczyk A; Krzanowski T; Janowska S; Malm A; Wujec M
Chem Biodivers; 2019 Oct; 16(10):e1900377. PubMed ID: 31436917
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL
Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
Pavlović D; Mutak S
Bioorg Med Chem; 2016 Mar; 24(6):1255-67. PubMed ID: 26860929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
